Skip to main content

Vasoplegia clinical trials at UCSF

1 research study open to eligible people

When blood pressure drops a lot, it's called vasoplegia. UCSF is doing a study to see if Angiotensin II, a blood pressure raising drug, is safe and works well during liver transplants.

Showing trials for
  • Angiotensin II in Liver Transplantation

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

    San Francisco, California

Our lead scientists for Vasoplegia research studies include .

Last updated: